Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01123421 · ClinicalTrials.gov registry record
Develop and Validate Ultrasonic Device for Osteoporotic Fracture Risk Assessment
A clinical trial, sponsored by Artann Laboratories.
- Completed
- Registry status
- 113
- Enrollment target
NCT01123421 is a clinical trial that has completed, run by Artann Laboratories. The registered enrollment target is 113 participants.
The verdict
NCT01123421 has completed, sponsored by Artann Laboratories.
- COMPLETED
- Registry status
- 113 participants
- Enrollment target
Study Summary
Study to demonstrate that the Bone UltraSonic Scanner (BUSS) can aid in detection of osteoporosis and predict prevalent osteoporotic fractures. Measurements derived from the BUSS parameters will be able to discriminate between postmenopausal women with osteoporotic fractures when compared to matched controls without history of osteoporotic fracture.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2010-05 |
| Est. Completion | 2012-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01123421
The ClinicalTrials.gov registry entry for NCT01123421 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Artann Laboratories, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01123421 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01123421 about?
NCT01123421 is a clinical study titled "Develop and Validate Ultrasonic Device for Osteoporotic Fracture Risk Assessment". Study to demonstrate that the Bone UltraSonic Scanner (BUSS) can aid in detection of osteoporosis and predict prevalent osteoporotic fractures. Measurements derived from the BUSS parameters will be able to discriminate between postmenopausal women with osteoporotic fractures when compared to matched...
What is the current status of trial NCT01123421?
This trial is currently completed. The enrollment target is 113 participants. The study started on 2010-05. Estimated completion is 2012-02.
Who is sponsoring clinical trial NCT01123421?
This trial is sponsored by Artann Laboratories, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.